Association of Infliximab and Vedolizumab Trough Levels with Reported Rates of Adverse Events: A Cross-Sectional Study

por Veisman, Ido, Barzilay, Oranit, Bruckmayer, Liora, Haj-Natour, Ola, Kopylov, Uri, Eliakim, Rami, Ben-Horin, Shomron, Ungar, Bella
Publicado 2021